13F-HR/A filed by Endurant Capital Management LP
Endurant Capital Management LP filed this 13F-HR/A for the quarter ended 2021-06-30, filed 2021-08-27, with 57 holding rows worth $363,842,000.
- Accession
- 0001633055-21-000007
- Filer
- CIK 1633055
- Filed
- 2021-08-27
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, amendment of type restatement, 57 entries on the cover page, a total value of $363,842,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $363,842,000 with VALUE read as thousands by filing date, 13F file number 028-16634. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INVACARE CORP | 461203AJ0 | NOTE 5.000%11/1 | 37,566,000 | $36,638,000 | thousands by filing date | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 62,919 | $17,356,000 | thousands by filing date | |
| Cigna Corporation | 125523100 | COM | 71,856 | $17,035,000 | thousands by filing date | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 79,415 | $16,416,000 | thousands by filing date | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 29,679 | $14,972,000 | thousands by filing date | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 217,891 | $14,597,000 | thousands by filing date | |
| R1 RCM INC | 749397105 | COM | 548,876 | $12,207,000 | thousands by filing date | |
| SYNEOS HEALTH INC | 87166B102 | CL A | 130,238 | $11,655,000 | thousands by filing date | |
| INVACARE CORP | 461203101 | COMMON STOCK | 1,374,840 | $11,095,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 85,514 | $9,632,000 | thousands by filing date | |
| ELUTIA INC | 05479K106 | CL A COM | 873,159 | $8,391,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 570,970 | $8,096,000 | thousands by filing date | |
| PHASEBIO PHARMACEUTICALS INC | 717224109 | COM | 2,129,709 | $7,923,000 | thousands by filing date | |
| HAEMONETICS CORP MASS COM | 405024100 | Stock | 117,904 | $7,857,000 | thousands by filing date | |
| EARGO INC | 270087109 | COM | 193,471 | $7,721,000 | thousands by filing date | |
| BIO RAD LABS INC | 090572207 | CL A | 11,820 | $7,616,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 260,314 | $7,409,000 | thousands by filing date | |
| HOLOGIC INC | 436440101 | COM | 110,840 | $7,395,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 15,791 | $6,991,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 101,081 | $6,754,000 | thousands by filing date | |
| DENTSPLY SIRONA INC | 24906P109 | COM | 103,860 | $6,570,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 1,539,435 | $6,558,000 | thousands by filing date | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 748,013 | $5,849,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 600,788 | $5,828,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 140,211 | $5,606,000 | thousands by filing date | |
| INSMED INC | 457669AB5 | NOTE 0.750% 6/0 | 5,000,000 | $5,539,000 | thousands by filing date | |
| DARIOHEALTH CORP | 23725P209 | COM | 258,774 | $5,527,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 32,998 | $5,436,000 | thousands by filing date | |
| AVANTOR INC COM | 05352A100 | Stock | 152,395 | $5,412,000 | thousands by filing date | |
| CENCORA INC COM | 03073E105 | Stock | 41,729 | $4,778,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 11,941 | $4,559,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 51,031 | $4,429,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 139,124 | $4,298,000 | thousands by filing date | |
| CALLIDITAS THERAPEUTICS AB SPONSERED | 13124Q106 | ADS | 144,393 | $4,252,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 160,362 | $4,173,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 926,935 | $3,875,000 | thousands by filing date | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 199,565 | $3,648,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 103,512 | $3,642,000 | thousands by filing date | |
| MEDAVAIL HOLDINGS INC | 58406B103 | COM | 292,196 | $3,579,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 5,563 | $3,107,000 | thousands by filing date | |
| TELEFLEX INCORPORATED | 879369106 | COM | 7,501 | $3,014,000 | thousands by filing date | |
| ACCENDRA HEALTH INC | 690732102 | COM | 66,989 | $2,836,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 756,915 | $2,399,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 28,625 | $2,225,000 | thousands by filing date | |
| IMMUNIC INC | 4525EP101 | COM | 177,148 | $2,172,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K200 | COM NEW | 2,607,674 | $2,120,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 119,378 | $2,096,000 | thousands by filing date | |
| BAXTER INTL INC | 071813109 | COM | 25,059 | $2,017,000 | thousands by filing date | |
| PENNANT GROUP INC | 70805E109 | COM | 47,475 | $1,942,000 | thousands by filing date | |
| FORTE BIOSCIENCES INC | 34962G109 | COM | 53,369 | $1,794,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 7,553 | $1,523,000 | thousands by filing date | |
| SI BONE INC | 825704109 | COM | 40,155 | $1,264,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 406,537 | $1,264,000 | thousands by filing date | |
| CELYAD ONCOLOGY SA | 151205200 | ADR | 160,691 | $845,000 | thousands by filing date | |
| CANO HEALTH INC | 13781Y103 | COM | 62,013 | $750,000 | thousands by filing date | |
| PROVENTION BIO INC | 74374N102 | COM | 82,960 | $699,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 70,969 | $461,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001633055-21-000006 | superseded | 2021-08-16 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001633055-21-000007 | this filing | 2021-08-27 | acceptance time not in the bulk data set |